Skip to content
    CJ Investment logo

    CJ Investment

    Seoul, South KoreaFounded 2000

    CJ Investment (formerly Timewise Investment) is the corporate venture capital arm of CJ Corporation, based in Seoul, South Korea. Founded in 2000 as Dream Discovery and renamed multiple times, it invests in content, bio, ICT, food & distribution, and media sectors to develop new growth engines for the CJ Group.

    Their most common stage is series-a (53% of deals). Average disclosed round size is $17.1M (across 19 rounds with reported amounts).

    Find people at CJ Investment on Goldilocks AI

    Portfolio

    29

    Fund Size

    —

    Top Stage

    Series A

    Last 12 Mo

    0

    Team

    JS

    Jason Silverman

    Managing Partner

    CB

    Charlie Brown

    Note Investor

    CR

    Christopher Raiser

    Real Estate Investor/Private Equity

    HK

    Hyoseb Kim

    Venture Capitalist

    YJ

    Ye Joo Kim

    Investment Manager

    DK

    Dohan Kim

    대표이사 (CEO)

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    38 investments
    CompanyRoundAmountDate
    Rootrix logoRootrixSeries A—Jan 2026
    Liner logoLinerSeries C$36.1MJan 2026
    Colosseum Corporation logoColosseum CorporationSeries A—Jun 2025
    IM Biologics logoIM BiologicsIpo$28.7MJan 2025
    Colosseum Corporation logoColosseum CorporationSeries B$20.8MJan 2025
    Colosseum logoColosseumSeries B$20.8MJun 2024
    Liner logoLinerSeries C$36.1MJan 2024
    PlayTag logoPlayTagSeries A—May 2023
    IM Biologics logoIM BiologicsSeries B$2.0MJan 2023
    Mobiltech logoMobiltechSeries B$2.3MJan 2023
    PlayTag logoPlayTagUnknown—Jan 2023
    AAfun interactiveSeries A—Jan 2023
    GGoPizzaSeries C$20MOct 2022
    AAmazeVRUnknown$17MJan 2022
    Nex-i logoNex-iSeries A—Jan 2022
    Liner logoLinerSeries B$7.1MJan 2022
    Modhaus logoModhausSeries A—Jan 2022
    Elorea logoEloreaSeed$2MJan 2022
    S Alpha Therapeutics logoS Alpha TherapeuticsSeed$8.7MJul 2021
    IM Biologics logoIM BiologicsSeries A$2.0MJan 2021
    S Alpha Therapeutics logoS Alpha TherapeuticsSeries A$8.7MJan 2021
    SS-alpha TherapeuticsSeries A$8.7MJan 2021
    Nex-i logoNex-iSeries A—Jan 2021
    Zamface logoZamfaceSeries A—Aug 2020
    Bunjang logoBunjangUnknown—Jan 2020
    Page 1 of 2

    Top Co-Investors

    Last updated: 20 October 2026